Does short stem THA Improve Accuracy of Femoral Stem Positioning in the Axial Plane: a Randomized Clinical Trial, Comparing Two Implant Philosophies - A2® short-stem RCT

Charite Berlin, Centrum für Muskuloskeletale Chirurgie0 个研究点目标入组 40 人开始时间: 2021年11月18日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Patients may be included in the study only if they meet the following criteria:
•Patient is eligible to A2 (ARTIQO GmbH) and SL-Plus MIA (Smith & Nephew Orthopaedics AG) total hip arthroplasty
•Patient is able to provide informed consent
•Patient is willing to attend all follow-up visits and complete all study requirements
•Patient is willing to adhere to the rehabilitation protocol
•Patient has one of the following indications:
•o Primary osteoarthritis of the hip
•o Avascular necrosis, posttraumatic osteoarthritis, rheumatoid arthritis
•o Displaced femoral neck fracture
•Patient has sufficient bone quality for total hip arthroplasty.
•Note: patients can only enter the project with one hip.

•Acute or chronic infections, local or systemic
•Severe muscular, nervous or vascular diseases impairing the affected limb
•Missing bone substance or poor bone quality, which jeopardizes stable fit of the prosthesis
•Previous operations that no longer guarantee stability of the prosthesis
•Pronounced coxa valga with a femoral neck angle> 145°
•Pronounced coxa vara with a femoral neck angle <120°
•Any concomitant disease that may jeopardizes functioning of the implant
•Arthroplasty revision procedures.

发起方

Charite Berlin, Centrum für Muskuloskeletale Chirurgie